Information  X 
Enter a valid email address

Smith & Nephew Plc (SN.)

  Print      Mail a friend       Annual reports

Wednesday 20 November, 2019

Smith & Nephew Plc

Director/PDMR Shareholding

RNS Number : 0491U
Smith & Nephew Plc
20 November 2019
 

 

SMITH & NEPHEW PLC

 

20 November 2019

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Skip Kiil

2

Reason for the notification

a)

Position/status

Person Discharging Managerial Responsibilities ('PDMR')

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

 

ISIN: GB0009223206

b)

Nature of the transaction

Sale of ordinary shares.

c)

Price(s) and volume(s)

Price(s)

£16.610227

Volume(s)

10,907

d)

Aggregated information

- Aggregated volume

- Price

Single Transaction

N/A

N/A

e)

Date of the transaction

2019 - 11 - 15

f)

Place of the transaction

The London Stock Exchange (XLON)

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  01923 477410


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLIFLALSLIFIA

a d v e r t i s e m e n t